<?xml version="1.0" encoding="UTF-8"?>
<resource xmlns="http://datacite.org/schema/kernel-4" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://datacite.org/schema/kernel-4 http://schema.datacite.org/meta/kernel-4/metadata.xsd">
<identifier identifierType="DOI">https://doi.org/10.48539/HBM458.NSWR.957</identifier>
<titles>
  <title>OMAP-1 Organ Mapping Antibody Panel (OMAP) for Multiplexed Antibody-Based Imaging of Human Lymph Node with IBEX, v1.3</title>
</titles>
<creators>
  <creator>
    <creatorName>Andrea J. Radtke</creatorName>
    <givenName>Andrea</givenName>
    <familyName>Radtke</familyName>
    <nameIdentifier nameIdentifierScheme="ORCID" schemeURI="https://orcid.org/0000-0003-4379-8967">0000-0003-4379-8967<nameIdentifier>
  </creator>
</creators>
<publisher>HuBMAP</publisher>
<publicationYear>2023</publicationYear>
<resourceType resourceTypeGeneral="Dataset">Organ Mapping Antibody Panel</resourceType>
<subjects>
  <subject>OMAP-1 Organ Mapping Antibody Panel (OMAP) for Multiplexed Antibody-Based Imaging of Human Lymph Node with IBEX</subject>
<subjects>
<contributors>
  <contributor contributorType="ProjectLeader">
      <contributorName>Andrea J. Radtke</contributorName>
      <givenName>Andrea</givenName>
      <familyName>Radtke</familyName>
      <nameIdentifier nameIdentifierScheme="ORCID" schemeURI="https://orcid.org/0000-0003-4379-8967">0000-0003-4379-8967<nameIdentifier>
  </contributor>
  <contributor contributorType="ProjectLeader">
      <contributorName>Katy Börner</contributorName>
      <givenName>Katy</givenName>
      <familyName>Börner</familyName>
      <nameIdentifier nameIdentifierScheme="ORCID" schemeURI="https://orcid.org/0000-0002-3321-6137">0000-0002-3321-6137<nameIdentifier>
  </contributor>
  <contributor contributorType="ProjectLeader">
      <contributorName>Neil Kelleher</contributorName>
      <givenName>Neil</givenName>
      <familyName>Kelleher</familyName>
      <nameIdentifier nameIdentifierScheme="ORCID" schemeURI="https://orcid.org/0000-0002-8815-3372">0000-0002-8815-3372<nameIdentifier>
  </contributor>
  <contributor contributorType="ProjectLeader">
      <contributorName>Ronald N. Germain</contributorName>
      <givenName>Ronald</givenName>
      <familyName>Germain</familyName>
      <nameIdentifier nameIdentifierScheme="ORCID" schemeURI="https://orcid.org/0000-0003-1495-9143">0000-0003-1495-9143<nameIdentifier>
  </contributor>
  <contributor contributorType="Other">
    <contributorName>Elaine Jaffe</contributorName>
    <givenName>Elaine</givenName>
    <familyName>Jaffe</familyName>
    <nameIdentifier nameIdentifierScheme="ORCID" schemeURI="https://orcid.org/0000-0003-4632-0301">0000-0003-4632-0301<nameIdentifier>
  </contributor>
  <contributor contributorType="Other">
    <contributorName>Stefania Pittaluga</contributorName>
    <givenName>Stefania</givenName>
    <familyName>Pittaluga</familyName>
    <nameIdentifier nameIdentifierScheme="ORCID" schemeURI="https://orcid.org/0000-0001-7688-1439">0000-0001-7688-1439<nameIdentifier>
  </contributor>
  <contributor contributorType="Other">
    <contributorName>Ronald N. Germain</contributorName>
    <givenName>Ronald</givenName>
    <familyName>Germain</familyName>
    <nameIdentifier nameIdentifierScheme="ORCID" schemeURI="https://orcid.org/0000-0003-1495-9143">0000-0003-1495-9143<nameIdentifier>
  </contributor>
  <contributor contributorType="Other">
    <contributorName>Ellen M. Quardokus</contributorName>
    <givenName>Ellen</givenName>
    <familyName>Quardokus</familyName>
    <nameIdentifier nameIdentifierScheme="ORCID" schemeURI="https://orcid.org/0000-0001-7655-4833">0000-0001-7655-4833<nameIdentifier>
  </contributor>
  <contributor contributorType="Other">
    <contributorName>Christopher Werlein</contributorName>
    <givenName>Christopher</givenName>
    <familyName>Werlein</familyName>
    <nameIdentifier nameIdentifierScheme="ORCID" schemeURI="https://orcid.org/0000-0002-7694-4257">0000-0002-7694-4257<nameIdentifier>
  </contributor>
  <contributor contributorType="Other">
    <contributorName>Diane C. Saunders</contributorName>
    <givenName>Diane</givenName>
    <familyName>Saunders</familyName>
    <nameIdentifier nameIdentifierScheme="ORCID" schemeURI="https://orcid.org/0000-0002-8849-6746">0000-0002-8849-6746<nameIdentifier>
  </contributor>
  <contributor contributorType="Other">
    <contributorName>Anna Martinez Casals</contributorName>
    <givenName>Anna</givenName>
    <familyName>Casals</familyName>
    <nameIdentifier nameIdentifierScheme="ORCID" schemeURI="https://orcid.org/0000-0003-2722-1965">0000-0003-2722-1965<nameIdentifier>
  </contributor>
  <contributor contributorType="Other">
    <contributorName>Presha Rajbhandari</contributorName>
    <givenName>Presha</givenName>
    <familyName>Rajbhandari</familyName>
    <nameIdentifier nameIdentifierScheme="ORCID" schemeURI="https://orcid.org/0000-0003-2184-7238">0000-0003-2184-7238<nameIdentifier>
  </contributor>
</contributors>
<dates>
  <date dateType="Available">2023-06-15</date>
</dates>
<descriptions>
  <description>OMAP-1 was designed for IBEX (Iterative Bleaching Extends multi-pleXity) imaging of fixed frozen human lymph nodes (https://doi.org/10.1038/s41596-021-00644-9; https://doi.org/10.1073/pnas.2018488117). The panel contains 39 antibodies and the nuclear marker Hoechst 33342 for image alignment and nuclear segmentation. his OMAP provides a spatial context for all anatomical structures and most cell types present in the [ASCT+B lymph node table, v1.1](https://doi.org/10.48539/HBM573.SHCQ.259). Additionally, the inclusion of protein biomarkers BCL2, CD10, CD138, and CD44 allow profiling of lymph node disease states, e.g. follicular lymphoma and metastasis. The core and prioritized OMAP targets detailed here overlap (~50-85%) with panels developed for multiplexed imaging of lymphoid samples using other technologies and sample preparations (https://doi.org/10.7554/eLife.31657, https://doi.org/10.1002/eji.202048891). This OMAP does not contain antibodies for typing pericytes, plasmacytoid dendritic cells, or different T helper lineages (Th1, Th2, Th17). Beyond spatial mapping of healthy human lymph nodes, this OMAP was used to characterize the tissue microenvironment of follicular lymphoma lymph nodes. For this study, object-based cellular segmentation was performed using a convolutional neural network (CNN)-based approach with Mask R-CNN architecture and ResNet-50 as a backbone. As an input three channels were used: Hoechst for nuclei, CD45 as a base membrane, and composite of several other membrane markers (CD138, CD163, CD94, CD69, CD8, CD4). More details and accompanying datasets associated with OMAP-1 can be found here (https://doi.org/10.1101/2022.06.03.494716, https://doi.org/10.5281/zenodo.5244550). Several antibodies required custom conjugation by commercial suppliers or antibody conjugation kits (e.g., AF532, Thermo A20182).</description>
</decsriptions>
<language>EN</language>
<alternateIdentfiers>
  <alternateIdentfier alternateIdentiferType="HuBMAP ID">HBM458.NSWR.957</alternateIdentfier>
  <alternateIdentfier alternateIdentfierType="How to Cite This OMAP Tables">Andrea J. Radtke. Organ Mapping Antibody Panel (OMAP) for Multiplexed Antibody-Based Imaging of Human Lymph Node with IBEX v1.3. https://doi.org/10.48539/HBM458.NSWR.957. Accessed on June 23, 2023.</alternateIdentfier>
  <alternateIdentfier alternateIdentfierType="How to Cite OMAP Tables Overall">Hickey, John W., Elizabeth K. Neumann, Andrea J. Radtke, Jeannie M. Camarillo, Rebecca T. Beuschel, Alexandre Albanese, Elizabeth McDonough, et al. 2021. “Spatial Mapping of Protein Composition and Tissue Organization: A Primer for Multiplexed Antibody-Based Imaging.” *Nature Methods*, November. https://doi.org/10.1038/s41592-021-01316-y.</alternateIdentfier>
</alternateIdentfiers>
<formats>
	<format>.csv</format>
</formats>
<rightsList>
  <rights rightsURI="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International (CC BY 4.0)</rights>
</rightsList>
<fundingReferences>
	<fundingReference>
		<funderName>National Institutes of Health</funderName>
		<awardNumber>OT2OD026671</awardNumber>
	</fundingReference>
</fundingReferences>
</resource>
